Krystal Biotech Inc
SWB:4KB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Krystal Biotech Inc
SWB:4KB
|
US |
|
T
|
Titan Machinery Inc
XBER:3TY
|
US |
|
Grupo Aeroportuario del Sureste SAB de CV
OTC:ASRMF
|
MX |
|
Fujitsu Ltd
TSE:6702
|
JP |
|
D
|
D'Ieteren Group NV
DUS:DJDA
|
BE |
|
Q
|
Qingdao Port International Co Ltd
XMUN:0QP
|
CN |
|
U
|
US Gold Corp
F:DTUR
|
US |
|
G Rent SpA
F:7F3
|
IT |
|
SPS Commerce Inc
F:S86
|
US |
|
S
|
Stericycle Inc
DUS:SY9
|
US |
|
Money Forward Inc
F:47D
|
JP |
|
B
|
Biotest AG
XETRA:BIO0
|
DE |
|
T
|
Targa Resources Corp
LSE:0LD9
|
US |
|
Ease2pay NV
F:DOC2
|
NL |
|
D
|
Deutsche Post AG
BMV:DPWN
|
DE |
|
Pexip Holding ASA
OTC:PXPHF
|
NO |
Wall St Price Targets
4KB Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for 4KB is 266.32 EUR with a low forecast of 180.68 EUR and a high forecast of 324.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4KB's stock price target?
Price Target
266.32
EUR
According to Wall Street analysts, the average 1-year price target for 4KB is 266.32 EUR with a low forecast of 180.68 EUR and a high forecast of 324.13 EUR.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
17%
The compound annual growth rate for Revenue over the next 8 years is 17%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
26%
The compound annual growth rate for Operating Income over the next 8 years is 26%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
16%
The compound annual growth rate for Net Income over the next 7 years is 16%.
